NIC
MRNA icon

Northwest Investment Counselors’s Moderna MRNA Stock Holding History

Northwest Investment Counselors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.34K Buy
+20
New +$1.84K ﹤0.01% 578
2024
Q2 		– Sell
-20
Closed -$2.13K – 374
2024
Q1 		$2.13K Buy
+20
New +$2.02K ﹤0.01% 484
2023
Q4 		– Sell
-45
Closed -$4.65K – 384
2023
Q3 		$4.65K Sell
45
-8
-15% -$892 ﹤0.01% 450
2023
Q2 		$6.44K Buy
53
+8
+18% +$1.07K ﹤0.01% 428
2023
Q1 		$6.91K Hold
45
– – ﹤0.01% 431
2022
Q4 		$8.08K Buy
45
+20
+80% +$3.27K ﹤0.01% 418
2022
Q3 		$3K Buy
+25
New +$3.79K ﹤0.01% 476

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northwest Investment Counselors's MRNA Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in Moderna (MRNA) in Q3 2024: 20 shares worth $1.34K. The stake represents ﹤0.01% of the portfolio and ranks #578 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in MRNA as recently as Q1 2024.

Northwest Investment Counselors first reported a position in MRNA in Q3 2022 and has held it in 7 quarters since. The position peaked at $8.08K in Q4 2022. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Northwest Investment Counselors held 20 shares of Moderna worth $1.34K as of Q3 2024.
  • Moderna was a new Northwest Investment Counselors position in Q3 2024.
  • Moderna made up ﹤0.01% of Northwest Investment Counselors's portfolio in Q3 2024, its #578 holding.
  • Northwest Investment Counselors first reported a position in Moderna in Q3 2022 and has held it in 7 quarters since.
  • Northwest Investment Counselors's Moderna position peaked at $8.08K in Q4 2022.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.